APOE and Alzheimer disease: We extend previous work, first, by comparing, for the first time, aging-related decline slopes of odor identification and non-olfactory cognitive tests, and second, by investigate how the APOE-ɛ4, the most prominent genetic risk factor for late-onset AD, influences the longitudinal trajectories of these assessments.